Harrow Inc (HROW)
10.38
-0.26
(-2.44%)
USD |
NASDAQ |
May 03, 16:00
10.38
0.00 (0.00%)
After-Hours: 20:00
Harrow Max Drawdown (5Y): 71.15% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 71.15% |
| March 31, 2024 | 71.15% |
| February 29, 2024 | 71.15% |
| January 31, 2024 | 71.15% |
| December 31, 2023 | 71.15% |
| November 30, 2023 | 71.15% |
| October 31, 2023 | 59.77% |
| September 30, 2023 | 59.77% |
| August 31, 2023 | 59.77% |
| July 31, 2023 | 74.94% |
| June 30, 2023 | 74.94% |
| May 31, 2023 | 74.94% |
| April 30, 2023 | 75.61% |
| March 31, 2023 | 75.95% |
| February 28, 2023 | 76.17% |
| January 31, 2023 | 80.11% |
| December 31, 2022 | 82.40% |
| November 30, 2022 | 84.40% |
| October 31, 2022 | 84.40% |
| September 30, 2022 | 84.60% |
| August 31, 2022 | 85.80% |
| July 31, 2022 | 85.80% |
| June 30, 2022 | 88.00% |
| May 31, 2022 | 88.00% |
| April 30, 2022 | 88.00% |
| Date | Value |
|---|---|
| March 31, 2022 | 88.00% |
| February 28, 2022 | 88.00% |
| January 31, 2022 | 88.00% |
| December 31, 2021 | 88.00% |
| November 30, 2021 | 88.00% |
| October 31, 2021 | 88.00% |
| September 30, 2021 | 88.93% |
| August 31, 2021 | 88.93% |
| July 31, 2021 | 88.93% |
| June 30, 2021 | 88.93% |
| May 31, 2021 | 88.93% |
| April 30, 2021 | 88.93% |
| March 31, 2021 | 88.93% |
| February 28, 2021 | 88.93% |
| January 31, 2021 | 88.93% |
| December 31, 2020 | 88.93% |
| November 30, 2020 | 88.93% |
| October 31, 2020 | 88.93% |
| September 30, 2020 | 88.93% |
| August 31, 2020 | 88.93% |
| July 31, 2020 | 88.93% |
| June 30, 2020 | 88.93% |
| May 31, 2020 | 88.93% |
| April 30, 2020 | 88.93% |
| March 31, 2020 | 88.93% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
59.77%
Minimum
Aug 2023
90.94%
Maximum
May 2019
83.68%
Average
88.00%
Median
Oct 2021
Max Drawdown (5Y) Benchmarks
| Aquestive Therapeutics Inc | 96.68% |
| Cyclacel Pharmaceuticals Inc | 99.50% |
| Lifecore Biomedical Inc | 89.19% |
| Relmada Therapeutics Inc | 95.67% |
| Corvus Pharmaceuticals Inc | 95.28% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 8.47 |
| Beta (5Y) | 0.5761 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 65.23% |
| Historical Sharpe Ratio (5Y) | 0.2283 |
| Historical Sortino (5Y) | 0.455 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 26.34% |